GE HealthCare Technologies Aktie 123735674 / US36266G1076
84.90
USD
2.40
USD
2.91%
20.11.2024
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
GE HealthCare Technologies Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | GE HealthCare Technologies | 0.16 | 0.12 | USD |
| 2022 | GE HealthCare Technologies | 0.00 | 0.00 | USD |
| 2021 | GE HealthCare Technologies | - | - | USD |
| 2020 | GE HealthCare Technologies | - | - | USD |
| 2019 | GE HealthCare Technologies | - | - | USD |
Gewinn je Aktie- GE HealthCare Technologies
| 3.4 19 | 4.4 20 | 4.9 21 | 4.2 22 | 3.0 23 |
Umsatz je Aktie- GE HealthCare Technologies
| 36.6 19 | 37.7 20 | 38.7 21 | 40.4 22 | 42.7 23 |
KGV- GE HealthCare Technologies
| 13.8 22 | 25.6 23 |
GE HealthCare Technologies: Die Aktie (in USD)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 3.35 | 4.41 | 4.90 | 4.22 | 3.03 |
| Gewinn je Aktie unverwässert | 3.35 | 4.41 | 4.90 | 4.22 | 3.04 |
| Gewinn je Aktie verwässert | 3.35 | 4.41 | 4.90 | 4.22 | 3.02 |
| Dividende pro Aktie | - | - | - | 0.00 | 0.12 |
| Gesamtdividendenausschüttung in Mio. | 0.00 | 0.00 | 0.00 | 0.00 | 41.00 |
GE HealthCare Technologies: Unternehmenskennzahlen (in USD)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Umsatz je Aktie | 36.58 | 37.75 | 38.67 | 40.41 | 42.69 |
| KGV (Jahresendkurs, EPS unverwässert) | - | - | - | 13.83 | 25.57 |
| KGV (Jahresendkurs, EPS verwässert) | - | - | - | 13.83 | 25.57 |
| KGV (Jahresendkurs) | - | - | - | 13.83 | 25.57 |
| Dividendenrendite Jahresende in % | - | - | - | 0.00 | 0.16 |
| Eigenkapitalquote in % | - | 61.80 | 64.22 | 34.83 | 22.52 |
| Fremdkapitalquote in % | - | 38.20 | 35.78 | 65.17 | 77.48 |
GE HealthCare Technologies: GuV (in Mio. USD)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Umsatzerlöse | 16’633.00 | 17’164.00 | 17’585.00 | 18’341.00 | 19’552.00 |
| Umsatzveränderung in % | - | 3.19 | 2.45 | 4.30 | 6.60 |
| Bruttoergebnis vom Umsatz | 6’548.00 | 6’767.00 | 7’174.00 | 7’221.00 | 7’956.00 |
| Bruttoergebnisveränderung in % | - | 3.34 | 6.01 | 0.66 | 10.18 |
| Operatives Ergebnis | 2’124.00 | 2’720.00 | 2’795.00 | 2’564.00 | 2’788.00 |
| Veränderung Operatives Ergebnis in % | - | 28.06 | 2.76 | -8.26 | 8.74 |
| Ergebnis vor Steuern | 2’091.00 | 2’710.00 | 2’875.00 | 2’512.00 | 2’361.00 |
| Veränderung Ergebnis vor Steuern in % | - | 29.60 | 6.09 | -12.63 | -6.01 |
| Ergebnis nach Steuer | 1’652.00 | 2’007.00 | 2’229.00 | 1’898.00 | 1’572.00 |
| Veränderung Ergebnis nach Steuer in % | - | 21.49 | 11.06 | -14.85 | -17.18 |
GE HealthCare Technologies: Bilanz (in Mio. USD)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | - | 9’254 | 9’412 | 17’947 | 25’144 |
| Langzeit Gesamtverbindlichk. pro Aktie | - | 6.00 | 5.83 | 23.70 | 35.50 |
| Eigenkapital | - | 14’974 | 16’896 | 9’592 | 7’310 |
| Veränderung Eigenkapital in % | - | - | 13.09 | -43.82 | -23.77 |
| Bilanzsumme | - | 24’228 | 26’308 | 27’539 | 32’454 |
| Veränderung Bilanzsumme in % | - | - | 8.59 | 4.68 | 17.85 |
GE HealthCare Technologies: Sonstige Angaben (in USD)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 3.35 | 4.41 | 4.90 | 4.22 | 3.04 |
| Veränderung Gewinn je Aktie (unverwässert) in % | - | 31.69 | 11.06 | -13.89 | -27.88 |
| Gewinn je Aktie (verwässert) | 3.35 | 4.41 | 4.90 | 4.22 | 3.02 |
| Veränderung Gewinn je Aktie (verwässert) in % | - | 31.69 | 11.06 | -13.89 | -28.36 |
| Anzahl Mitarbeiter | - | - | - | 50’000 | 51’000 |
| Veränderung Anzahl Mitarbeiter in % | - | - | - | - | 2.00 |
GE HealthCare Technologies Termine
| Unternehmen | Event | Datum |
|---|---|---|
| GE HealthCare Technologies | Quartalszahlen | 03.02.2025 |
| GE HealthCare Technologies | Quartalszahlen | 29.04.2025 |
| GE HealthCare Technologies | Quartalszahlen | 29.07.2025 |
| GE HealthCare Technologies | Quartalszahlen | 29.10.2025 |
GE HealthCare Technologies vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 30.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 31.07.2024 |
| Hauptversammlung | Annual General Meeting | 21.05.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 30.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 06.02.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 31.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 25.07.2023 |
| Hauptversammlung | Annual General Meeting | 23.05.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 25.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 30.01.2023 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 96.85 |
| Capital Research & Management Co. (Global Investors) | 12.75 |
| Capital Research & Management Co. (Global Investors) | 12.75 |
| Vanguard Group, Inc. (Subfiler) | 10.60 |
| The Vanguard Group, Inc. | 10.18 |
| American Funds Investment Company of America | 4.75 |
| State Street Corp. | 4.08 |
| Dodge & Cox | 3.65 |
| BlackRock Fund Advisors | 3.28 |
| Vanguard Total Stock Market ETF | 3.01 |
| American Funds Growth Fund of America | 2.98 |
| General Electric Co. (Investment Company) | 2.91 |
| GE Aerospace | 2.91 |
| Vanguard 500 Index Fund | 2.62 |
| Geode Capital Management LLC | 2.40 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 50’000 | 51’000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.37 | 0.38 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 0 | 5’448 | 6’543 | 7’819 | 9’010 |
| Summe Anlagevermögen | 0 | 18’780 | 19’765 | 19’720 | 23’444 |
| Summe Aktiva | 0 | 24’228 | 26’308 | 27’539 | 32’454 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 0 | 468 | 437 | 8’635 | 9’863 |
| Summe Fremdkapital | 0 | 9’254 | 9’412 | 17’947 | 25’144 |
| Summe Eigenkapital | 0 | 14’974 | 16’896 | 9’592 | 7’310 |
| Summe Passiva | 0 | 24’228 | 26’308 | 27’539 | 32’454 |
Adresse
| 500 West Monroe Street, 60661 Chicago | |
| Telefon | +1 (833) 735-1139 |
| URL | http://www.gehealthcare.com |
Management
|
Abigail Epane-Osuala
Chief Diversity, Equity & Inclusion Officer |
|
Adam Holton
Chief People Officer |
|
Anne T. Madden
Independent Director |
|
Brian Montgomery
Chief Strategy Officer |
|
Carolynne Borders
Chief Investor Relations Officer |
|
Catherine A. Lesjak
Independent Director |
|
Danielle Halstrom
Chief Marketing & Communications Officer |
|
Frank R. Jimenez
Secretary & General Counsel |
|
George Newcomb
Chief Accounting Officer & Controller |
|
H. Lawrence Culp
Non-Executive Chairman |
|
Jahid Khandaker
Chief Information Officer |
|
James K. Saccaro
Chief Financial Officer & Vice President |
|
Kenneth R. Stacherski
Chief Supply Chain & Services Officer |
|
Laila A. Gurney
Chief Quality & Regulatory Officer |
|
Lloyd W. Howell
Independent Director |
|
Parminder Bhatia
Chief AI Officer |
|
Peter J. Arduini
President, Chief Executive Officer & Director |
|
Philip D. Rackliffe
President & Chief Executive Officer-Ultrasound |
|
Phoebe L. Yang
Independent Director |
|
Rana Strellis
Chief Corporate Marketing & Communications Officer |
|
Risa J. Lavizzo-Mourey
Lead Independent Director |
|
Rodney F. Hochman
Independent Director |
|
Roland Rott
Chief Executive Officer-Imaging |
|
Taha Kass-Hout
Chief Science & Technology Officer |
|
Thomas J. Westrick
Chief Executive Officer-Patient Care Solutions |
|
Tomislav Mihaljevic
Independent Director |
|
William Joseph Stromberg
Independent Director |